Mesanenin nadir görülen kanserleri: Olgu serisi ve literatürün gözden geçirilmesi

Year 2014, , 767 - 772, 01.12.2014

Taha Numan Yıkılmaz Okan Baş Ali İhsan Arık Fatih Hızlı Halil Başar

https://doi.org/10.5798/diclemedj.0921.2014.04.0518

Cited By: 2

Abstract

Kliniğimizde mesane tümörü tanısıyla opere edilen olgular retrospektif olarak değerlendirildi. Bu olgulardan nadir patolojiye sahip olanlar belirlendi. Literatür incelenerek mesanenin nadir görülen tümörleri araştırıldı. Kliniğimizdeki tanı ve tedavi algoritmaları literatür ile karşılaştırıldı. Mesanenin nadir görülen tümörleri çoğu ürolog ve patolog tarafından tanınamamaktadır. Bu nedenle ilk tanı esnasında ve tedavi sırasında zorluklara neden olabilmektedir.

Keywords

Mesane kanseri, adenokanser, taşlı yüzük hücreli kanser, yassı hücreli kanser, nöroendokrin tümörler

Rare malignancies of the bladder: Case series and review of the literature

Abstract

Patients who operated the diagnosis with bladder cancer were evaluated retrospectively. Patients with a rare pathology was determined. Rare tumors of the bladder was investigated by examining the literature. Our clinic diagnosis and treatment algorithms were compared with the literature. A rare tumor of the bladder cannot be recognized by most urologists and pathologists. Therefore, it can cause difficulties during diagnosis and treatment.

Keywords

Bladder cancer, adenocarcinoma, signet ring cell carcinoma, squamous cell carcinoma, neuroendocrine tumors

References

• Citgez S, Erözenci A, Yörükoğlu K. Non-ürotelyal mesane kanserleri. Üroonkoloji Bülteni 2007;4:9-14.
• Manunta A, Vincendeau S, Kiriakou G, Lobel B, Guillé F. Non-transitional cell bladder carcinomas. BJU Int. 2005;95:497-502.
• Wood DP. Urothelial tumors of the bladder. In. Walsh PC ed. Campbell’s Urology, 10th edn. Philedelphia: Saunders, 2012:2308-2333.
• Gadalla HA, Kamel NA, Badary FA, Elanany FG. Expres- sion of CD44 protein in bilharzial and non-bilharzial blad- der cancers. BJU Int. 2004;93:151-155.
• Youssef RF, von Rundstedt FC, Kapur P et al. Utility of bio- markers in the prediciton of oncological outcome after radi- cal cystectomy for squamous cell carcinoma. J Urol 2014. [Epub ahead of print]
• Swanson DA, Liles A, Zagars GK. Preoperative irradiation and radical cystectomy for stages T2 and T3 squamous cell carcinoma of the bladder. J Urol 1990;143:37-40.
• Dahm P, Gschwend JE. Malignant non-urothelial neoplasms of the urinary bladder: a review. Eur Urol 2003;44:672-681.
• Ghoneim MA, el-Mekresh MM, el-Baz MA, et al. Radical cystectomy for carcinoma of the bladder: critical evalua- tion of the results in 1,026 cases. J Urol 1997;158:393-399.
• Şahin H. Mesanenin az görülen kanserlerinde yaklaşım. Üro- onkoloji Bülteni 2012; 11:14-18.
• El-Sebaie M, Zaghloul MS, Howard G, Mokhtar A. Squa- mous cell carcinoma of the bilharzial and non-bilharzial urinary bladder: a review of etiological features, natural history, and management. Int J Clin Oncol 2005;10:20-25.
• Peterson RO. Urologic Pathology. 2nd edn. Philadelphia: Lippincott company, 1986;288-384.
• Roy S, Parwani AV. Adenocarcinoma of the urinary bladder. Arch Pathol Lab Med 2011;135:1601-1605.
• Wilson TG, Pritchett TR, Lieskovsky G, et al. Primary ad- enocarcinoma of bladder. Urology 1991;38:223-226.
• Holmäng S, Aldenborg F. Stage T1 adenocarcinoma of the urinary bladder- complete response after transurethral re- section and intravesical bacillus Calmette-Guerin. Scand J Urol Nephrol 2000;34:141-143.
• Zaghloul MS, Nouh A, Nazmy M, et al. Long-term results of primary adenocarcinoma of the urinary bladder: a report on 192 patients. Urol Oncol 2006;24:13-20.
• Kıroğlu Y, Yerlikaya İ, Erkuş M. Mesanenin taşlı yüzük hücreli karsinomu. Turk Patoloji Derg 1992;8:79-80.
• Akamatsu S, Takahashi A, Ito M, Ogura K. Primary sig- net-ring cell carcinoma of the urinary bladder. Urology 2010;75:615-618.
• Türkölmez K. Mesanenin değişici epitel dışı kanserlerinde tanı ve tedavi. In: Özen H, Türkeri L eds. Üroonkoloji ki- tabı, 1. Basım. Ankara: Ertem Basım Yayın, 2007:375-387.
• Hamakawa T, Kojima Y, Naiki T, et al. Long-term survival of a patient with invasive signet- ring cell carcinoma of the urinary bladder managed by combined s-1 and Cisplatin adjuvant chemotherapy. Case Rep Urol 2013. [Epub 2013 May 8]
• Blute ML, Engen DE, Travis WD, Kvols LK. Primary signet ring cell adenocarcinoma of the bladder. J Urol 1989;141:17-21.
• Vincendeau S, de Lajarte-Thirouard AS, Bensalah K, et al. Neuroendocrine differentiation of bladder tumors. Prog Urol 2003;13:375-384.
• Cerulli C, Busetto GM, Antonini G, et al. Primary metastat- ic neuroendocrine small cell bladder cancer: A case report and literature review. Urol Int 2012;88:365-369.
• Çallı AO, Uyaroğlu MA, Sarı A, ve ark. Mesanenin küçük hücreli kanseri: olgu sunumu. Turk Urol Derg 2005;31:596- 598.
• Cheng L, Pan CX, Yang XJ, et al. Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients. Cancer 2004;101:957-962.
• Coelho HM, Pereira BA, Caetano PA. Large cell neuroen- docrine carcinoma of the urinary bladder: case report and review. Curr Urol 2013;7:155-159.
• Quek ML, Nichols PW, Yamzon J, et al. Radical cystec- tomy for primary neuroendocrine tumors of the bladder: the university of southern california experience. J Urol 2005;174:93-96.